DOI : 10.1055/s-00000041

Neuropediatrics

Issue 01 · Volume 35 · February 2004 DOI: 10.1055/s-002-3101


Abstracts for the 30th Annual Meeting of the Society for Neuropediatrics (Gesellschaft für Neuropädiatrie)
Bern, Switzerland, March 25–28, 2004

M. Steinlin

P51
Bevot, A.; Krägeloh-Mann, I.; Tydeman, C.; Flodmark, O.; Bax, M.: The European cerebral palsy study: magnetic resonance imaging (MRI) and clinical findings
P54
Schelle, A.; Linder, M.; Michaelis, U.; Brückner, J.; Schessl, J.; Walther, M.; Korinthenberg, R.; Mall, V.: Off-label-use of botulinum toxin a (BTX A) in pediatric patients
P55
Berweck, S.; Gerstl, J.; Fietzek, U. M.; Gutmann, I.; Schwerin, A.; Francke, A.; Heinen, F.: Multilevel treatment – safety of the 12Plus-concept with botulinum toxin A (Botox®)
P56
Gerstl, J.; Schroeder, A. S.; Schwerin, A.; Fietzek, U. M.; Berweck, S.: Analgosedation in children treated with botulinum-toxin – efficacy and side effects
P58
Zafeiriou, D. I.; Pavlou, E.; Vargiami, E.; Hytopoulos, A.; Tryfonas, D.; Kontopoulos, E.; Tsikoulas, I.: Botulinum toxin type A treatment in children with spastic cerebral palsy: documentation of the short-term effect with general motor function-measure (GMFM)